Dr Samuel Arparicio, BC Cancer Research Centre
Defining the role of clonal genomes in the evolution and treatment of cancers
Dr Artem Cherkasov, University of British Columbia
Using methods of chemical genomics for developing nuclear receptor inhibitors with novel modes of action
Dr David Huntsman, BC Cancer Agency
Contextual genomics: The foundation for subtype specific approaches to ovarian cancer control
Dr Torsten Nielsen, The Provincial Health Services Authority Research Centre
Fusion gene sarcomas: translating basic science into clinical care
Dr Raewin Broady, University of British Columbia
Generation of antigen specific T regulatory cells to treat GVHD post allogeneic stem cell transplant
Dr Colin Collins, Vancouver Hospital and Health Sciences Centre
Identification of critical players driving development of treatment resistant neuroendocrine prostate cancer
Dr Dirk Lange, University of British Columbia
The use of caulobacter crescentus as a novel microbial approach to treat bladder cancer
Dr Brad Nelson, BC Cancer Agency (Victoria)
The mutated lymphoma genome: A target for therapeutic vaccination
Dr Ryan Rhodes, University of Victoria
Exercise games and physical activity: Does multi-player online play improve adherence?
Dr Michel Roberge, University of British Columbia
Chemical inhibition of SQSTM1/p62 in pancreatic cancer
Dr Jeremy Wulff, University of Victoria
Small-molecule inhibitors of the PD1-PDL1 interaction for treating metastatic cancer
John Oliffe, University of British Columbia
Smoke-free men: translating research findings through a tobacco reduction website for cancer prevention action